Author

Virginia Vila‐del Sol

Servicio de Salud de Castilla La ManchaORCID 0000-0002-5606-2767Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Diego ClementeiD· 2 shared María Cristina OrtegaiD· 2 shared Alejandra Palomino‐AntolíniD· 1 shared Ana Belén López-RodrígueziD· 1 shared Celia Camacho-ToledanoiD· 1 shared Celine Decouty‐PéreziD· 1 shared Denise C. FitzgeraldiD· 1 shared Elena Fernández‐LópeziD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Diego ClementeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid-Derived Suppressor Cells are relevant factors to predict the severity of multiple sclerosis

María Cristina Ortega, Rafael Lebrón‐Galán, Isabel Machín-Díaz, Michelle Naughton, Inmaculada Pérez-Molina, Jennifer García-Arocha, José Manuel García‐Domínguez, Haydee Goicoechea-Briceño, Virginia Vila‐del Sol, Víctor Quintanero-Casero, Rosa García-Montero, Victoria Galán, Celia Camacho-Toledano, María Luisa Martínez‐Ginés, Denise C. Fitzgerald, Diego Clemente

The paper identifies myeloid-derived suppressor cells (M-MDSCs) as biomarkers for predicting milder clinical courses in multiple sclerosis.

bioRxiv · Apr 20, 2022 · PreprintNeuroscience

TLR4-pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury

Juliana M. Rosa, Víctor Farré‐Alins, María Cristina Ortega, Marta Navarrete, Ana Belén López-Rodríguez, Alejandra Palomino‐Antolín, Elena Fernández‐López, Virginia Vila‐del Sol, Celine Decouty‐Pérez, Paloma Narros‐Fernández, Diego Clemente, Javier Egea

This study shows that TLR4-pathway activation in astrocytes after TBI leads to synaptic loss and BBB damage, which can be mitigated by TLR4 inhibition.

British Journal of Pharmacology · Apr 8, 2021Peer-reviewedNeuroscience